View in EDS

Dimeric Fcγ Receptor Enzyme-Linked Immunosorbent Assay To Study HIV-Specific Antibodies: A New Look into Breadth of Fcγ Receptor Antibodies Induced by the RV144 Vaccine Trial.

Saved in:
Bibliographic Details
Title: Dimeric Fcγ Receptor Enzyme-Linked Immunosorbent Assay To Study HIV-Specific Antibodies: A New Look into Breadth of Fcγ Receptor Antibodies Induced by the RV144 Vaccine Trial.
Authors: McLean MR; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Parkville, Melbourne, Victoria 3000, Australia., Madhavi V; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Parkville, Melbourne, Victoria 3000, Australia., Wines BD; Centre for Biomedical Research, Burnet Institute, Melbourne, Victoria 3004, Australia.; Department of Immunology, Monash University Central Clinical School, Melbourne, Victoria 3004, Australia.; Department of Pathology, The University of Melbourne, Parkville, Melbourne, Victoria 3010, Australia., Hogarth PM; Centre for Biomedical Research, Burnet Institute, Melbourne, Victoria 3004, Australia.; Department of Immunology, Monash University Central Clinical School, Melbourne, Victoria 3004, Australia.; Department of Pathology, The University of Melbourne, Parkville, Melbourne, Victoria 3010, Australia., Chung AW; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Parkville, Melbourne, Victoria 3000, Australia; skent@unimelb.edu.au awchung@unimelb.edu.au., Kent SJ; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Parkville, Melbourne, Victoria 3000, Australia; skent@unimelb.edu.au awchung@unimelb.edu.au.; Melbourne Sexual Health Centre, Infectious Diseases Department, Alfred Health, Monash University Central Clinical School, Melbourne, Victoria 3053, Australia; and.; Australian Research Council Centre of Excellence in Convergent Bio-Nano Science and Technology, The University of Melbourne, Parkville, Melbourne, Victoria 3010, Australia.
Source: Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2017 Jul 15; Vol. 199 (2), pp. 816-826. Date of Electronic Publication: 2017 Jun 14.
Publication Type: Clinical Trial, Phase III; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 2985117R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1550-6606 (Electronic) Linking ISSN: 00221767 NLM ISO Abbreviation: J Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 28615419
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Dimeric Fcγ Receptor Enzyme-Linked Immunosorbent Assay To Study HIV-Specific Antibodies: A New Look into Breadth of Fcγ Receptor Antibodies Induced by the RV144 Vaccine Trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22McLean+MR%22">McLean MR</searchLink>; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Parkville, Melbourne, Victoria 3000, Australia.<br /><searchLink fieldCode="AU" term="%22Madhavi+V%22">Madhavi V</searchLink>; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Parkville, Melbourne, Victoria 3000, Australia.<br /><searchLink fieldCode="AU" term="%22Wines+BD%22">Wines BD</searchLink>; Centre for Biomedical Research, Burnet Institute, Melbourne, Victoria 3004, Australia.; Department of Immunology, Monash University Central Clinical School, Melbourne, Victoria 3004, Australia.; Department of Pathology, The University of Melbourne, Parkville, Melbourne, Victoria 3010, Australia.<br /><searchLink fieldCode="AU" term="%22Hogarth+PM%22">Hogarth PM</searchLink>; Centre for Biomedical Research, Burnet Institute, Melbourne, Victoria 3004, Australia.; Department of Immunology, Monash University Central Clinical School, Melbourne, Victoria 3004, Australia.; Department of Pathology, The University of Melbourne, Parkville, Melbourne, Victoria 3010, Australia.<br /><searchLink fieldCode="AU" term="%22Chung+AW%22">Chung AW</searchLink>; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Parkville, Melbourne, Victoria 3000, Australia; skent@unimelb.edu.au awchung@unimelb.edu.au.<br /><searchLink fieldCode="AU" term="%22Kent+SJ%22">Kent SJ</searchLink>; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Parkville, Melbourne, Victoria 3000, Australia; skent@unimelb.edu.au awchung@unimelb.edu.au.; Melbourne Sexual Health Centre, Infectious Diseases Department, Alfred Health, Monash University Central Clinical School, Melbourne, Victoria 3053, Australia; and.; Australian Research Council Centre of Excellence in Convergent Bio-Nano Science and Technology, The University of Melbourne, Parkville, Melbourne, Victoria 3010, Australia.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%222985117R%22">Journal of immunology (Baltimore, Md. : 1950)</searchLink> [J Immunol] 2017 Jul 15; Vol. 199 (2), pp. 816-826. <i>Date of Electronic Publication: </i>2017 Jun 14.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase III; Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>2985117R <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1550-6606 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200221767%22">00221767 </searchLink><i>NLM ISO Abbreviation: </i>J Immunol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=28615419
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.4049/jimmunol.1602161
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 816
    Titles:
      – TitleFull: Dimeric Fcγ Receptor Enzyme-Linked Immunosorbent Assay To Study HIV-Specific Antibodies: A New Look into Breadth of Fcγ Receptor Antibodies Induced by the RV144 Vaccine Trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: McLean MR
      – PersonEntity:
          Name:
            NameFull: Madhavi V
      – PersonEntity:
          Name:
            NameFull: Wines BD
      – PersonEntity:
          Name:
            NameFull: Hogarth PM
      – PersonEntity:
          Name:
            NameFull: Chung AW
      – PersonEntity:
          Name:
            NameFull: Kent SJ
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 15
              M: 07
              Text: 2017 Jul 15
              Type: published
              Y: 2017
          Identifiers:
            – Type: issn-electronic
              Value: 1550-6606
          Numbering:
            – Type: volume
              Value: 199
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Journal of immunology (Baltimore, Md. : 1950)
              Type: main
ResultId 1